Application 202071
- Type
- ANDA
- Sponsor
- NOVELGENIX THERAPS
Application Products
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | POLYETHYLENE GLYCOL 3350 | POLYETHYLENE GLYCOL 3350 | FOR SOLUTION;ORAL | 17GM/SCOOPFUL | No | No |
NDC Listings For This Application
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 10135-683 | Polyethylene Glycol 3350 | Polyethylene Glycol 3350 | Marlex Pharmaceuticals Inc | ANDA | Current |
| 14539-150 | POLYETHYLENE GLYCOL 3350 | POLYETHYLENE GLYCOL 3350 | Emcure Pharmaceuticals USA Inc. | ANDA | Current |